Alcohol abuse and alcoholism remain major causes of ill-health and human suffering in the western world at an astronomical expense. In fact, a report of 1990 figures indicates that alcohol-related problems resulted in $140 billion in capital expenditure. Since recent studies suggest that the occurrence of alcohol abuse could be highly influenced by the presence or absence of key metabolizing enzymes across ethnic populations, the elaborate ethnic bonds and cultural syntax that accrue from ethnicity may indeed serve to improve or worsen biological fitness. Thus, alcohol abuse, alcoholism and the disastrous toll in human lives and property that arise therefrom (across populations), do so only with some degree of complicity, with ethno-genetic factors. To further understand the complex interplay of factors between alcohol and ethno-genetics, this pilot study proposes to determine how alcohol dehydrogenase (ADH2) genotypes and liver volume (LV) influence alcohol elimination rate (AER), using the Indiana Breath Alcohol Clamping (BrAC) technique. It is hypothesized that the ADH2 genotype and LV are the primary determinants of AER within ethnic populations.
The Specific Aims therefore, are to: 1) Identify the frequency of the ADH2 genotypes across ethnic groups (African Americans--AF-AM; Africans [Nigerians]--AF-Ni; Africans [Ethiopians]--AF-Et; and Caucasians--CAU), 2) Determine LV across ethnic groups (African Americans--AF-AM; Africans [Nigerians]--AF-Ni; Africans [Ethiopians]--AF-Et; and Caucasians--CAU), 3) Assess the influence on AER within defined ADH2 genotype (ADH2*1), and 4) Compare AER between ADH2*1 and ADH2*3 genotypes for a defined range of LV.

Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Howard University
Department
Type
DUNS #
056282296
City
Washington
State
DC
Country
United States
Zip Code
20059
Christensen, Kurt D; Uhlmann, Wendy R; Roberts, J Scott et al. (2018) A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genet Med 20:132-141
Doumatey, Ayo P; He, William J; Gaye, Amadou et al. (2018) Circulating MiR-374a-5p is a potential modulator of the inflammatory process in obesity. Sci Rep 8:7680
Guan, Yue; Roter, Debra L; Wolff, Jennifer L et al. (2018) The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease. Patient Educ Couns 101:817-823
Mullins, Tanya L Kowalczyk; Li, Su X; Bethel, James et al. (2018) Sexually transmitted infections and immune activation among HIV-infected but virally suppressed youth on antiretroviral therapy. J Clin Virol 102:7-11
Faruque, Mezbah U; Chen, Guanjie; Doumatey, Ayo P et al. (2017) Transferability of genome-wide associated loci for asthma in African Americans. J Asthma 54:1-8
Guan, Yue; Roter, Debra L; Erby, Lori H et al. (2017) Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study. Patient Educ Couns 100:927-935
Nandakumar, Priyanka; Lee, Dongwon; Richard, Melissa A et al. (2017) Rare coding variants associated with blood pressure variation in 15?914 individuals of African ancestry. J Hypertens 35:1381-1389
Lieberman, Richard; Armeli, Stephen; Scott, Denise M et al. (2016) FKBP5 genotype interacts with early life trauma to predict heavy drinking in college students. Am J Med Genet B Neuropsychiatr Genet 171:879-87
Christensen, Kurt D; Roberts, J Scott; Whitehouse, Peter J et al. (2016) Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial. Ann Intern Med 164:155-63
Armeli, Stephen; O'Hara, Ross E; Covault, Jon et al. (2016) Episode-specific drinking-to-cope motivation and next-day stress-reactivity. Anxiety Stress Coping 29:673-84

Showing the most recent 10 out of 205 publications